pf-07901801

Small moleculeexperimental

Clinical trial activity

4 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Dec 7, 2022 (NCT05626322)

Timeline

2020s

  1. Jan 1, 2022

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2022

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05896163Phase 2Aug 30, 2023Pfizer, Roche
NCT05896774Phase 1Jun 28, 2023Pfizer
NCT05675449Phase 1Dec 14, 2022Pfizer
NCT05626322Phase 2Dec 7, 2022Incyte, MorphoSys, Pfizer
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
PfizerFor profit4422022
IncyteFor profit1012022
MorphoSysFor profit1012022
RocheFor profit1012023
4 organizations
Page 1 / 1